Cargando…

Effects of homoarginine supplementation on heart and skeletal muscle of rats with heart failure with preserved ejection fraction

AIM: Heart failure with preserved ejection fraction (HFpEF) is associated with left ventricular stiffness, impaired diastolic relaxation, and severe exercise intolerance. Decreased homoarginine (hArg) levels are an independent predictor of mortality in cardiovascular disease and correlate with impai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Büttner, Petra, Adams, Volker, Werner, Sarah, Ossmann, Susann, Besler, Christian, Schwedhelm, Edzard, Thiele, Holger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773648/ https://www.ncbi.nlm.nih.gov/pubmed/36043453 http://dx.doi.org/10.1002/ehf2.14110

Ejemplares similares

Systemic Effects of Homoarginine Supplementation on Arginine Metabolizing Enzymes in Rats with Heart Failure with Preserved Ejection Fraction
por: Büttner, Petra, et al.
Publicado: (2023)

Arginine metabolism and nitric oxide turnover in the ZSF1 animal model for heart failure with preserved ejection fraction
por: Büttner, Petra, et al.
Publicado: (2021)

Tubulin expression and modification in heart failure with preserved ejection fraction (HFpEF)
por: Schulz, Lisa, et al.
Publicado: (2022)

Evaluation of phosphodiesterase 9A as a novel biomarker in heart failure with preserved ejection fraction
por: Besler, Christian, et al.
Publicado: (2021)

Homoarginine and creatine deficiency do not exacerbate murine ischaemic heart failure
por: McAndrew, Debra J., et al.
Publicado: (2022)

Analysis of L-arginine:glycine amidinotransferase-, creatine- and homoarginine-dependent gene regulation in the murine heart
por: Jensen, Märit, et al.
Publicado: (2020)

Population kinetics of homoarginine and optimized supplementation for cardiovascular risk reduction
por: Kleist, Christine J., et al.
Publicado: (2022)

Skeletal muscle phenotypic switching in heart failure with preserved ejection fraction
por: Saw, Eng Leng, et al.
Publicado: (2022)

Creatine, guanidinoacetate and homoarginine in statin-induced myopathy
por: Neu, Axel, et al.
Publicado: (2020)

Transcriptomic Research in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives
por: Rosch, Sebastian, et al.
Publicado: (2020)

Structural and functional alterations in heart and skeletal muscle following severe TAC in mice: impact of moderate exercise training
por: Böttner, Julia, et al.
Publicado: (2021)

Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trials
por: Kresoja, Karl-Patrik, et al.
Publicado: (2023)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Developmental dynamics of homoarginine, ADMA and SDMA plasma levels from birth to adolescence
por: Baach, Florence, et al.
Publicado: (2023)

Loss of skeletal muscle mass predicts cardiac death in heart failure with a preserved ejection fraction but not heart failure with a reduced ejection fraction
por: Matsumura, Koichiro, et al.
Publicado: (2020)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Right Heart Phenotype in Heart Failure With Preserved Ejection Fraction
por: Guazzi, Marco, et al.
Publicado: (2021)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Deep learning detects heart failure with preserved ejection fraction using a baseline electrocardiogram
por: Unterhuber, Matthias, et al.
Publicado: (2021)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
por: Lin, Tin‐Kwang, et al.
Publicado: (2019)

Low Homoarginine Levels in the Prognosis of Patients With Acute Chest Pain
por: Atzler, Dorothee, et al.
Publicado: (2016)

Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction
por: Zordoky, Beshay N., et al.
Publicado: (2015)

Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction
por: Samson, Rohan, et al.
Publicado: (2016)

Animal models of heart failure with preserved ejection fraction
por: Conceição, G., et al.
Publicado: (2016)

Cell Therapy for Heart Failure With Preserved Ejection Fraction
por: Borlaug, Barry A., et al.
Publicado: (2016)

Hospitalisation in Patients With Heart Failure With Preserved Ejection Fraction
por: Nanayakkara, Shane, et al.
Publicado: (2018)

Modelling the complexity of heart failure with preserved ejection fraction
por: O’Gallagher, Kevin, et al.
Publicado: (2018)

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
por: Zeng, Heng, et al.
Publicado: (2019)

Heart Failure With Preserved Ejection Fraction: An Opportunity for Reflection
por: Gupta, Deepak K.
Publicado: (2017)

Strategies for management of heart failure with preserved ejection fraction
por: Winchester, David E.
Publicado: (2019)

Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction
por: Kirkman, Danielle L., et al.
Publicado: (2020)

Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
por: D’Amario, Domenico, et al.
Publicado: (2019)

Therapeutic Stalemate in Heart Failure With Preserved Ejection Fraction
por: Samson, Rohan, et al.
Publicado: (2021)

The Gut Microbiome of Heart Failure With Preserved Ejection Fraction
por: Beale, Anna L., et al.
Publicado: (2021)

Cell Therapy in Heart Failure with Preserved Ejection Fraction
por: Frljak, Sabina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dav06ph6o5pk74emvh7f4cq3os